KIMBERLEE ROBINSON: Open Payments
NPI 1982285938 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 4 payments from 4 companies in 2025. Trend: 2023 $1,283 · 2024 $1,001 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
Products named: PYRUKYND, Veozah, ABILIFY MAINTENA, WAINUA.
Industry payments across MI — which companies pay providers there.
